Trials / Unknown
UnknownNCT03464032
A Study of BCD-135 in Patients With Advanced Solid Tumors
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients With Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Biocad · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients with Advanced Solid Tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BCD-135 | Monoclonal anti-PD-L1 antibody |
Timeline
- Start date
- 2017-10-31
- Primary completion
- 2018-05-31
- Completion
- 2018-10-31
- First posted
- 2018-03-13
- Last updated
- 2018-03-13
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT03464032. Inclusion in this directory is not an endorsement.